Does OSIMERTINIB Cause Cutaneous vasculitis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Cutaneous vasculitis have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.0% of all adverse event reports for OSIMERTINIB.
7
Reports of Cutaneous vasculitis with OSIMERTINIB
0.0%
of all OSIMERTINIB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Cutaneous vasculitis From OSIMERTINIB?
Of the 7 reports, 2 (28.6%) resulted in death, 3 (42.9%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Cutaneous vasculitis Listed in the Official Label?
Yes, Cutaneous vasculitis is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Cutaneous vasculitis?
METHOTREXATE (207)
ADALIMUMAB (193)
TOCILIZUMAB (161)
ETANERCEPT (148)
APIXABAN (131)
HYDROXYCHLOROQUINE (125)
LEFLUNOMIDE (116)
ABATACEPT (112)
ANAKINRA (112)
INFLIXIMAB (108)
Which OSIMERTINIB Alternatives Have Lower Cutaneous vasculitis Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN